In humans with obesity, CYP4A11 mRNA decreased by 50% while in NAFLD patients while CYP4A11 mRNA increases 4-fold [126], suggesting a differential regulation in liver disease progression. The gene discussed is CYP4A11; the disease is liver disorder.